High molar activity [11C]phosgene and its utilization in the synthesis of radiopharmaceuticals

Description of the granted funding

Carbon is present everywhere in the living nature and 11C-labelled molecules will behave the same way, chemically and biologically, as their unlabelled equivalents. This feature makes carbon-11 such an attractive radionuclide for positron emission tomography (PET). PET is a non-invasive functional and metabolic imaging technique that allows the quantification of biological and pharmacological processes in vivo. Because of the short half-life of carbon-11, rapid and efficient synthesis and analytical processes are needed. The aim of this project is to develop simple, robust and reliable automated synthesis methods to produce high molar activity [11C]phosgene, a secondary synthon for 11C-labelling, by utilizing excitation methods, such as high voltage discharge and UV-photons. A successful project can revolutionize the carbon-11 labelling chemistry of PET-radiopharmaceuticals with high molar activity and radiochemical yield.
Show more

Starting year

2020

End year

2024

Granted funding

Anna Kirjavainen Orcid -palvelun logo
549 421 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

332128

Fields of science

Chemical sciences

Research fields

Kemia

Identified topics

molecular biology, biochemistry